Therapeutic approach to severe hypertrophic obstructive cardiomyopathy with multivessel coronary artery disease;Enfoque terapéutico en la miocardiopatía hipertrófica obstructiva severa con enfermedad coronaria multivaso

Revista Espanola de Cardiologia

Volumn 52, Issue 5, 1999, Pages 343-347

  Pérez, Juan C Tascón ^a   González Trevilla, Agustín Albarrán ^a   Gutiérrez, Manuel Alonso ^a   Dussac, Javier Andreu ^a   Hernández, Felipe Hernández ^a   Sánchez, Violeta Sánchez ^a   García, Jesús Rodríguez ^a  

^a NONE

Author keywords

Coronary stent in hypertrophic obstructive cardiomyopathy; DDD pacing and hypertrophic obstructive cardiomyopathy; Hypertrophic obstructive cardiomyopathy; Multivessel coronary angioplasty

Indexed keywords

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CORONARY ARTERY DISEASE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; PACEMAKER, ARTIFICIAL; STENTS;

EID: 0041706662     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)74925-0     Document Type: Article

References (9)

1. Maron BJ, Bonow RO, Cannon RO, Léon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987: 316: 780-789 y 844-852.
2. Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 1978; 57: 1.205-1.213.
3. Mohr R, Schaff H, Danielson GK, Puga FJ, Pluth JR, Tajik J. The outcome of surgical treatmen of hypertrophic obstructive cardiomyopathy. Experience over 15 years. J Thorac Cardiovasc Surg 1989; 97: 666-674.
4. Hassenstein P. Storch HH, Schmitz W. Erfahrungen mit der Schrittmacher dauerbehandlung bei patienten mit obstruktiver kardiomyopathie. Thoraxchirurgie 1975; 23: 496-498.
5. Tascón J, Albairán A, P-Carasa M, Andreu J, Rodríguez J, Coma R et al. Tratamiento de la miocardiopatía hipertrófica obstructiva refractaria al tratamiento médico con estimulación DDD. Rev Esp Cardiol 1994; 47: 294-302.
6. Fananapazir L, McAreavey M. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drugrefractory symptoms. J Am Coll Cardiol 1998; 31: 259-264.
7. Morrison DA, Bies RD, Sack J. Coronary angioplasty for ederly patient with «high risk» unstable angina: short-term outcomes and long-term survival. J Am Coll Cardiol 1997; 29: 339-344.
8. Kimura TK, Yokoi H, Nakagawa Y, Tamura T. Kaburagi S, Sawada Y et al. Three-year follow-up after implantation of metalic coronary-artery stents. N Engl J Med 1996; 334: 561-567.
9. Teixeira JM, Greenway PS, Staedtler C, Bareis R. Clinical Benefit of dual chamber pacing in hypertrophic cardiomyopathy: a case report. PACE 1996; 19: 120-123.